Navigation Links
Drug blocks two of world's deadliest emerging viruses
Date:3/5/2009

NEW YORK (March 5, 2009) -- Two highly lethal viruses that have emerged in recent outbreaks are susceptible to chloroquine, an established drug used to prevent and treat malaria, according to a new basic science study by researchers at Weill Cornell Medical College in the Journal of Virology. Due to the study's significance, a manuscript was published yesterday online, in advance of the print issue, and will be highlighted as an editor's "spotlight" in the first May issue.

The two henipaviruses that are the subject of the study -- Hendra Virus (HeV) and Nipah Virus (NiV) -- emerged during the 1990s in Australia and Southeast Asia. Harbored by fruit bats, they cause potentially fatal encephalitis and respiratory disease in humans, with a devastating 75 percent fatality rate. More recently, NiV outbreaks in Bangladesh involving human-to-human transmission have focused attention on NiV as a global health concern.

The researchers, based in Weill Cornell's pediatrics department, were surprised by their discovery that chloroquine, a safe, low-cost agent that has been used to combat malaria for more than 50 years, is a highly active inhibitor of infection by Hendra and Nipah.

"The fact that chloroquine is safe and widely used in humans means that it may bypass the usual barriers associated with drug development and move quickly into clinical trials," says Dr. Anne Moscona, professor of pediatrics and microbiology & immunology at Weill Cornell Medical College and senior author of the study. She is also vice chair for research of pediatrics at NewYork-Presbyterian Hospital/Weill Cornell Medical Center.

"Chloroquine stands a good chance of making it through the development process in time to prevent further outbreaks of these deadly infections," adds Dr. Moscona.

Like the avian flu, SARS, and Ebola viruses, Hendra and Nipah are zoonotic pathogens. That means they originate in certain animals but can jump between
'/>"/>

Contact: Andrew Klein
ank2017@med.cornell.edu
212-821-0560
New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Drug blocks 2 of worlds deadliest emerging viruses
2. NLRB Blocks New Organizations Attempts to Divide UHW; SEIU UHW Committed to Securing Good Contracts With Members
3. Beta Blocker Blocks Feelings of Bad Memories
4. USC study finds that green tea blocks benefits of cancer drug
5. Jefferson researchers show antibody to breast cancer-secreted protein blocks metastasis
6. Experimental agent blocks prostate cancer in animal study
7. C5 Medical Werks Applies for Clearance, Certification and Licensing for the Global Marketing of ZirDent(TM) Ceramic CAD/CAM Dental Blocks
8. Monkey Gene That Blocks AIDS Viruses Evolved More Than Once
9. Iowa State chemists track how drug changes, blocks flu virus
10. Super-Thin Drug-Free Coating Hides Stent as It Unblocks Heart Arteries
11. Grape powder blocks genes linked to colon cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:Researchers identify barriers to HPV vaccination uptake in low-income populations 2Health News:Researchers identify barriers to HPV vaccination uptake in low-income populations 3Health News:Orlando Company Develops New Technology Designed To Help Combat Hospital-Acquired Infections 2Health News:Orlando Company Develops New Technology Designed To Help Combat Hospital-Acquired Infections 3Health News:Securities Class Action Filed by Shepherd, Finkelman, Miller & Shah, LLP on Behalf of Hemispherx Biopharma Securities Purchasers Between February 18, 2009 and November 2, 2009 2Health News:Securities Class Action Filed by Shepherd, Finkelman, Miller & Shah, LLP on Behalf of Hemispherx Biopharma Securities Purchasers Between February 18, 2009 and November 2, 2009 3Health News:Securities Class Action Filed by Shepherd, Finkelman, Miller & Shah, LLP on Behalf of Hemispherx Biopharma Securities Purchasers Between February 18, 2009 and November 2, 2009 4Health News:New National Study Spotlights Importance of Federal Medicare Funding to Propping-Up Seniors' Deteriorating State Medicaid Benefits and Services 2Health News:New National Study Spotlights Importance of Federal Medicare Funding to Propping-Up Seniors' Deteriorating State Medicaid Benefits and Services 3Health News:Ophthonix Launches iZon(R) SL(TM) Polarized Lenses 2Health News:Ophthonix Launches iZon(R) SL(TM) Polarized Lenses 3
Breaking Medicine Technology:Ameritox(R) Appoints Jay B. Zimmerman as Chief Operating Officer 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 3Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 4Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 5Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 6Bayer Consumer Care Voluntarily Recalls One Lot of Combination Package of Alka-Seltzer Plus(R) Day & Night Cold Formula Liquid Gels 2New Swine Flu Strain Found in Brazil 3A Report 49266 1New Swine Flu Strain Found in Brazil 3A Report 49266 2New Swine Flu Strain Found in Brazil 3A Report 49266 3New Swine Flu Strain Found in Brazil 3A Report 49266 4New Swine Flu Strain Found in Brazil 3A Report 49266 5New Swine Flu Strain Found in Brazil 3A Report 49266 6New Swine Flu Strain Found in Brazil 3A Report 49266 7New Swine Flu Strain Found in Brazil 3A Report 49266 8New Swine Flu Strain Found in Brazil 3A Report 49266 9New Swine Flu Strain Found in Brazil 3A Report 49266 10New Swine Flu Strain Found in Brazil 3A Report 49266 11New Swine Flu Strain Found in Brazil 3A Report 49266 12Fathers 26apos 3B Hearing Affects Family Function and Fiscal Health 49263 1Fathers 26apos 3B Hearing Affects Family Function and Fiscal Health 49263 2Fathers 26apos 3B Hearing Affects Family Function and Fiscal Health 49263 3Fathers 26apos 3B Hearing Affects Family Function and Fiscal Health 49263 4MedNet Solutions Unveils New Naming and Functionality for its Flagship EDC eClinical Offering 12678 1MedNet Solutions Unveils New Naming and Functionality for its Flagship EDC eClinical Offering 12678 2